Two investment firms are teaming up to take a major health data software firm private in a $7.3 billion deal.
Invalon, which went public in 2015, helps pharmaceutical companies and healthcare providers manage and analyze data.
From Fierce Healthcare:
Health data software provider Inovalon is set to be acquired by Nordic Capital, Insight Partners and other investors in a deal valuing the company at roughly $7.3 billion.
Announced Aug. 18, the deal will take the tech company private and pay out $41 per share in cash to its stockholders—a roughly 25% bump over its value in late July, according to the announcement. Reuters and other sources peg the all-cash deal at $6.41 billion.
The acquisition is expected to close near the end of 2021 or the beginning of 2022 and is subject to regulatory and stockholder approval.
